Literature DB >> 27351360

The Impact of Respiratory Syncytial Virus Disease Prevention on Pediatric Asthma.

Mauricio T Caballero1, Marcus H Jones, Ruth A Karron, Tina V Hartert, Eric A F Simões, Renato T Stein, Niteen Wairagkar, Fernando P Polack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27351360     DOI： 10.1097/INF.0000000000001167

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  6 in total

1.  Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.

Authors:  Ursula J Buchholz; Coleen K Cunningham; Petronella Muresan; Devasena Gnanashanmugam; Paul Sato; George K Siberry; Vivian Rexroad; Megan Valentine; Charlotte Perlowski; Elizabeth Schappell; Bhagvinji Thumar; Cindy Luongo; Emily Barr; Mariam Aziz; Ram Yogev; Stephen A Spector; Peter L Collins; Elizabeth J McFarland; Ruth A Karron
Journal:  J Infect Dis       Date:  2018-04-11       Impact factor: 5.226

Review 2.  Respiratory syncytial virus is an "opportunistic" killer.

Authors:  Mauricio T Caballero; Fernando P Polack
Journal:  Pediatr Pulmonol       Date:  2018-02-20

3.  Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis.

Authors:  Corinne A Riddell; Niranjan Bhat; Louis J Bont; William D Dupont; Daniel R Feikin; Deshayne B Fell; Tebeb Gebretsadik; Tina V Hartert; Jennifer A Hutcheon; Ruth A Karron; Harish Nair; Robert C Reiner; Ting Shi; Peter D Sly; Renato T Stein; Pingsheng Wu; Heather J Zar; Justin R Ortiz
Journal:  Vaccine       Date:  2018-11-22       Impact factor: 3.641

Review 4.  Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade.

Authors:  Sofia S Aranda; Fernando P Polack
Journal:  Front Immunol       Date:  2019-05-07       Impact factor: 7.561

Review 5.  Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity.

Authors:  Diego R Hijano; Luan D Vu; Lawrence M Kauvar; Ralph A Tripp; Fernando P Polack; Stephania A Cormier
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

Review 6.  The long road to protect infants against severe RSV lower respiratory tract illness.

Authors:  Sofia Jares Baglivo; Fernando P Polack
Journal:  F1000Res       Date:  2019-05-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.